# Manager review — `progress_update.tex` (revision 2)

**Author:** research intern
**Reviewer:** research lead / manager
**Verdict:** Approve. Revisions addressed every point from the previous review. Below is a short list of meaningful follow-ups; none are blocking.

---

## What you fixed (good)

- **Research question up top.** Lands the framing in one sentence, exactly what was missing in v1.
- **Intended consumer named.** Internal eval, with an eye toward a paper / public release. Clear.
- **Dedicated "Validation experiment" section** with concrete inputs and three named metrics, including coverage-estimator calibration. This is now a falsifiable plan, not a vibe.
- **Risks & open questions** section added with three well-scoped items (plausible-but-wrong candidates, estimator independence assumption, single-reviewer noise). All three are the right risks to surface — they're the ones that would actually invalidate results.
- **Stage 2 wording fix** ("self-flags low-confidence candidates") — cleaner and no longer confusing for non-author readers.
- **TP / FP / partial / unsure / skip spelled out** on first mention. Small thing, real readability win.
- **"Different evidence-gathering strategy" → "needs a whole-table (or cross-table) view rather than chunked, per-row evidence"** — concrete, no longer hand-wavy.
- **Removed duplicate arrow chain** in status section.
- **Visual upgrade.** Section rules, callouts, a colour palette, and properly placed figure captions. Looks like a real research note, not a scratch doc. Worth the time it took.

## Meaningful follow-ups (non-blocking)

1. **State the cost-savings claim quantitatively, even roughly.** The research question hinges on "materially lower reviewer cost." A single line in the validation-experiment section pinning down what "materially lower" means (e.g. "target: ≥5× fewer cells reviewed for the same recall") would make the experiment a real test of the hypothesis, not just an evaluation.
2. **Microbenchmark size and selection.** "~200 cells covering all seven currently supported error types" — say which dataset slice, and how cells are selected (random rows? stratified by column?). Reproducibility hooks for whoever picks this up next.
3. **Recall denominator.** "Recall against the gold microbenchmark" needs one clarifying sentence: recall is computed against errors *in the microbenchmark*, not against all errors in the dataset. Otherwise it sounds like ground-truth-on-the-whole-table, which we don't have.
4. **Estimator-calibration metric is binary.** "Whether the 95% CI contains the true count" on a single microbenchmark gives one bit of evidence. Worth noting that real calibration needs many runs across many datasets — i.e. flag this as a *first* calibration check, not the final word.
5. **"Seven currently supported error types."** The taxonomy lists nine and you note multi-row + multi-table aren't done. Spell out which seven for the validation experiment so a reader doesn't have to subtract.
6. **Reviewer-noise mitigation.** You name single-reviewer noise as a risk but don't gesture at how it might be addressed (double-labelling a small subsample? agreement target?). One half-sentence is enough.

## Smaller polish (optional)

- The two callout boxes work well. Avoid a third — they lose impact when they multiply.
- Risks bullet 1 ("biasing the benchmark toward errors humans-and-LLMs both agree on") is the most interesting risk in the doc. Worth one extra sentence on how the validation experiment might detect this — e.g. inspecting a sample of FNs from the heuristic-disagreement set.
- "Hand-labelled microbenchmark of ~200 cells" + "Hand-label a sample of real data (~200 cells) to seed the first gold set" — the same fact in two places. Cite the validation section instead of restating.

## Things I'm explicitly *not* asking for

- Quantitative results yet — the validation experiment hasn't run.
- A timeline — research scope is fine to leave open mid-project.
- More detail on the coverage-estimator math — at this audience level, the current outcome-oriented framing is correct.

## Verdict

**Approve.** This is a substantively improved draft. The intern took the feedback seriously, added the right structural sections (research question, validation plan, risks), and the visual treatment is now appropriate for a note we can circulate. Address the cost-savings claim and the recall-denominator clarification before sharing externally; everything else is optional polish.

Solid work.
